BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It has been the subject of extensive preclinical research examining its effects on tissue repair signaling, wound healing pathways, angiogenesis, and tendon/ligament response modeling.

Mechanism of Action

BPC-157 is studied for its interaction with several growth factor systems, including vascular endothelial growth factor (VEGF) and nitric oxide (NO) signaling. Research suggests it promotes angiogenesis — the formation of new blood vessels — which is relevant to tissue repair and wound healing pathway studies. It is also examined for effects on the dopaminergic, serotonergic, and GABAergic systems in neurological pathway research.

Research Categories

Tendon and ligament repair: BPC-157 is frequently studied for its effects on tendon-to-bone healing, extracellular matrix remodeling, and fibroblast activity.

Gastrointestinal research: As a gastric peptide derivative, BPC-157 has been studied in models of GI mucosal protection and inflammatory bowel pathway research.

Neurological studies: Research examines BPC-157 in models of dopamine system modulation, trauma response, and neuroprotective pathway analysis.

Formulation and Documentation

BPC-157 is supplied as a lyophilized powder for research reconstitution. Researchers should verify batch-specific HPLC purity (≥98%) and mass spectrometry identity confirmation before use to ensure compound integrity and experimental reproducibility.

Research use only. Not for human or animal use. OligoPoly Labs supplies BPC-157 with third-party testing and batch-specific COA documentation.